Clotilde L’Angevin - Solid quarterly results

Sustained activity and accelerating development

Crédit Agricole is supporting the clinical development of UCPVax*, a universal therapeutic cancer vaccine born of more than fifteen years of research conducted by the Besançon Franche-Comté University Hospital and the Marie and Louis Pasteur University.

As part of its strategy to accelerate the industrial deployment of artificial intelligence, Crédit Agricole Artificial Intelligence, the Group’s AI company dedicated to pooling AI technology assets to support business transformation, announces the signing of a partnership with Mistral, a leading AI laboratory. Recently established, Crédit Agricole Artificial Intelligence is now fully operational and equipped to manage and secure the industrial-scale deployment of AI across the Group.

Crédit Agricole accelerates its growth in Germany with the launch of Crédit Agricole Deutschland 

A new division dedicated to the preservation, regeneration and enhancement of natural capital